enbucrilate has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadi, F; Hosseinzade, BE; Jahansooz, F; Massood Hojjati, SM; Shahpasand, K; Zarmi, AH | 1 |
1 other study(ies) available for enbucrilate and Parkinson Disease
| Article | Year |
|---|---|
Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Drug Carriers; Enbucrilate; Humans; Models, Animal; Nanoparticles; Parkinson Disease | 2020 |